Treatments for lung cancer have improved significantly over the last decade. During the last 10 years, newer medications have emerged that are helping people live longer and better quality lives. One of those discoveries was targeted therapies.
Because targeted therapies focus on killing cancer cells and spare the healthy cells, they tend to cause less side effects than chemotherapy.
Dr. Gomez is a Hematologist and Oncologist at Mount Sinai Hospital and an Assistant Professor of Medicine, Hematology, and Medical Oncology at the Icahn School of Medicine at Mount Sinai.
References
American Cancer Society. (2023). Treatment choices for non-small cell lung cancer, by stage.
American Cancer Society. (2022). Targeted therapy drugs for non-small cell lung cancer.
Guo, Q., et al. (2022). Current treatments for non-small cell lung cancer. Frontiers in Oncology.
Zhang, C, et al. (2019). Emerging therapies for non-small cell lung cancer. Journal of Hematology & Oncology.
Why trust our experts?
